Identification of leaky gut-related markers as indicators of metabolic health in Dutch adults: The Nutrition Questionnaires plus (NQplus) study

Background and aim Chronic inflammation is a primary risk factor for chronic metabolic disease and may be triggered by a “leaky gut.” Several biomarkers have been recognized to indicate intestinal permeability (i.e., leaky gut) and bacterial translocation. Nonetheless, which of these biomarkers exhibit the highest correlation with metabolic health parameters remains unclear. Hence, this study aimed to explore the correlation between leaky gut-related markers and metabolic health. Methods Based on waist circumference, plasma fasting glucose, plasma gamma-glutamyl transpeptidase (GGT), and plasma LDL cholesterol, two groups of 40 subjects with the most extreme metabolic health profiles were selected from the NQplus cohort study (n = 2048), which was previously conducted by the Wageningen University’s Division of Human Nutrition. Eight potential leaky gut-related markers were selected from the literature and measured in serum or EDTA plasma samples of these selected individuals. These samples were also obtained from the NQplus cohort study. Results From the leaky gut markers, levels of zonulin, lipopolysaccharide-binding protein, soluble CD14, bactericidal/permeability-increasing protein, and peptidoglycan were significantly higher in individuals with unhealthy metabolic profiles (p<0.05). No differences in EndoCAb IgM, EndoCAb IgA, and EndoCAb IgG were observed between healthy and unhealthy individuals. Stepwise regression analysis revealed that zonulin was substantially associated with metabolic health parameters such as BMI, blood glucose, triglyceride, GGT, and C-reactive protein levels. C-reactive protein, an inflammation marker, showed the most pronounced association with zonulin. Conclusions Biomarkers that link a leaky gut and subsequent bacterial translocation to metabolic health were identified in this study. Especially zonulin may aid in monitoring a leaky gut and detecting individuals at risk for developing chronic metabolic diseases.

[1]  E. Feskens,et al.  Nutrition Questionnaires plus (NQplus) study, a prospective study on dietary determinants and cardiometabolic health in Dutch adults , 2018, BMJ Open.

[2]  P. Nilsson,et al.  Higher Levels of Serum Zonulin May Rather Be Associated with Increased Risk of Obesity and Hyperlipidemia, Than with Gastrointestinal Symptoms or Disease Manifestations , 2017, International journal of molecular sciences.

[3]  Ho Min Kim,et al.  Dynamic lipopolysaccharide transfer cascade to TLR4/MD2 complex via LBP and CD14 , 2017, BMB reports.

[4]  T. Gosiewski,et al.  Comprehensive detection and identification of bacterial DNA in the blood of patients with sepsis and healthy volunteers using next-generation sequencing method - the observation of DNAemia , 2016, European Journal of Clinical Microbiology & Infectious Diseases.

[5]  E. Verna,et al.  Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of coeliac disease , 2016, Gut.

[6]  B. Schnabl,et al.  The Gut Microbiota and Liver Disease , 2015, Cellular and molecular gastroenterology and hepatology.

[7]  A. Gasbarrini,et al.  Intestinal permeability in non-alcoholic fatty liver disease: the gut-liver axis. , 2015, Reviews on recent clinical trials.

[8]  G. Gilkeson,et al.  Sex Differences in Monocyte Activation in Systemic Lupus Erythematosus (SLE) , 2014, PloS one.

[9]  B. Morio,et al.  Overfeeding increases postprandial endotoxemia in men: Inflammatory outcome may depend on LPS transporters LBP and sCD14. , 2014, Molecular nutrition & food research.

[10]  V. Mohan,et al.  Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes , 2014, Molecular and Cellular Biochemistry.

[11]  Saskia van Hemert,et al.  Clinical Studies Evaluating Effects of Probiotics on Parameters of Intestinal Barrier Function , 2013 .

[12]  J. Moreno-Navarrete,et al.  Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance , 2012, International Journal of Obesity.

[13]  Patrice D Cani,et al.  Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects , 2012, Brain, Behavior, and Immunity.

[14]  Y. Ilan.  Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis. , 2012, World journal of gastroenterology.

[15]  R. Alfenas,et al.  Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia , 2012, British Journal of Nutrition.

[16]  B. Fagerberg,et al.  Intestinal Permeability Is Associated With Visceral Adiposity in Healthy Women , 2011, Obesity.

[17]  H. Noguchi,et al.  Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease , 2011, Experimental diabetes research.

[18]  J. Stevens,et al.  Associations between gender, age and waist circumference , 2011, European Journal of Clinical Nutrition.

[19]  U. Singh,et al.  Human C-reactive protein and the metabolic syndrome , 2009, Current opinion in lipidology.

[20]  S. Heymsfield,et al.  Waist Circumference Correlates with Metabolic Syndrome Indicators Better Than Percentage Fat , 2006, Obesity.

[21]  J. Bramson,et al.  Protection from endotoxemia by adenoviral-mediated gene transfer of human bactericidal/permeability-increasing protein. , 2004, Blood.